Related references
Note: Only part of the references are listed.Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro
Valentina Citi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition
Yue Yu et al.
MOLECULAR CANCER (2018)
Regional Variation in Disparities in Breast Cancer Specific Mortality Due to Race/Ethnicity, Socioeconomic Status, and Urbanization
Carol A. Parise et al.
JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2017)
STC2 as a novel mediator for Mus81-dependent proliferation and survival in hepatocellular carcinoma
Fan Wu et al.
CANCER LETTERS (2017)
Burkholderia pseudomallei-derived miR-3473 enhances NF-κB via targeting TRAF3 and is associated with different inflammatory responses compared to Burkholderia thailandensis in murine macrophages
Yao Fang et al.
BMC MICROBIOLOGY (2016)
β3 integrin promotes chemoresistance to epirubicin in MDA-MB-231 through repression of the pro-apoptotic protein, BAD
Madhumathy G. Nair et al.
EXPERIMENTAL CELL RESEARCH (2016)
Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling
Chun-Hua Chang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2016)
The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in vitro
Sandra M. Ayuk et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2016)
Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis
M. Tandon et al.
ONCOGENE (2016)
Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy
Ting Hu et al.
SCIENTIFIC REPORTS (2016)
Stanniocalcin-2 (STC2): A potential lung cancer biomarker promotes lung cancer metastasis and progression
Sang-su Na et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress
Pyung-Hwan Kim et al.
BMB REPORTS (2015)
BCL-2 family protein, BAD is down-regulated in breast cancer and inhibits cell invasion
Maria Cekartova et al.
EXPERIMENTAL CELL RESEARCH (2015)
miR-190a inhibits epithelial-mesenchymal transition of hepatoma cells via targeting the long non-coding RNA treRNA
Xinyu Wang et al.
FEBS LETTERS (2015)
MicroRNA signatures highlight new breast cancer subtypes
Malay Bhattacharyya et al.
GENE (2015)
Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review
Hui Cao et al.
PATHOLOGY RESEARCH AND PRACTICE (2015)
The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism
Shaohua Xu et al.
SCIENTIFIC REPORTS (2015)
Stanniocalicin 2 Suppresses Breast Cancer Cell Migration and Invasion via the PKC/Claudin-1-Mediated Signaling
Jing Hou et al.
PLOS ONE (2015)
FOXO1 3′UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity
Jue Yang et al.
FEBS LETTERS (2014)
A novel estrogen receptor-microRNA 190a-PAR-1-pathway regulates breast cancer progression, a finding initially suggested by genome-wide analysis of loci associated with lymph-node metastasis
Hou-Wei Chu et al.
HUMAN MOLECULAR GENETICS (2014)
An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
Xin Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer
Kamal S. Saini et al.
CANCER TREATMENT REVIEWS (2013)
The shaping and functional consequences of the microRNA landscape in breast cancer
Heidi Dvinge et al.
NATURE (2013)
Transcriptional changes induced by the tumor dormancy-associated microRNA-190
Nava Almog et al.
TRANSCRIPTION-AUSTIN (2013)
STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro
Haixiao Wang et al.
BMB REPORTS (2012)
Loss of E-cadherin and Acquisition of Vimentin in Epithelial-Mesenchymal Transition are Noble Indicators of Uterine Cervix Cancer Progression
Na-Hye Myong
KOREAN JOURNAL OF PATHOLOGY (2012)
Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?
Julienne E. Bower et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia
Alice Y. S. Low et al.
EXPERIMENTAL CELL RESEARCH (2010)
ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1
E. Sanchez-Tillo et al.
ONCOGENE (2010)
Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China
Lei Fan et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer
Aoife J. Lowery et al.
BREAST CANCER RESEARCH (2009)
Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro
Sanda Raulic et al.
JOURNAL OF ENDOCRINOLOGY (2008)
Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins
Selma Esseghir et al.
CLINICAL CANCER RESEARCH (2007)
Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts
S. Esseghir et al.
JOURNAL OF PATHOLOGY (2006)
Share Paper
